Beaumont, P. (2020, May 27). French tests show even mild coronavirus illness leads to antibodies. The Guardian. https://www.theguardian.com/world/2020/may/27/french-team-finds-mild-coronavirus-infection-does-lead-to-antibodies

Pollán, M., Pérez-Gómez, B., Pastor-Barriuso, R., Oteo, J., Hernán, M. A., Pérez-Olmeda, M., Sanmartín, J. L., Fernández-García, A., Cruz, I., Larrea, N. F. de, Molina, M., Rodríguez-Cabrera, F., Martín, M., Merino-Amador, P., Paniagua, J. L., Muñoz-Montalvo, J. F., Blanco, F., Yotti, R., Blanco, F., … Villa, A. V. de la. (2020). Prevalence of SARS-CoV-2 in Spain (ENE-COVID): A nationwide, population-based seroepidemiological study. The Lancet, 0(0). https://doi.org/10.1016/S0140-6736(20)31483-5

Fontanet, A., Grant, R., Tondeur, L., Madec, Y., Grzelak, L., Cailleau, I., Ungeheuer, M.-N., Renaudat, C., Pellerin, S. F., Kuhmel, L., Staropoli, I., Anna, F., Charneau, P., Demeret, C., Bruel, T., Schwartz, O., & Hoen, B. (2020). SARS-CoV-2 infection in primary schools in northern France: A retrospective cohort study in an area of high transmission. MedRxiv, 2020.06.25.20140178. https://doi.org/10.1101/2020.06.25.20140178

Fontanet, A., Tondeur, L., Madec, Y., Grant, R., Besombes, C., Jolly, N., Pellerin, S. F., Ungeheuer, M.-N., Cailleau, I., Kuhmel, L., Temmam, S., Huon, C., Chen, K.-Y., Crescenzo, B., Munier, S., Demeret, C., Grzelak, L., Staropoli, I., Bruel, T., … Hoen, B. (2020). Cluster of COVID-19 in northern France: A retrospective closed cohort study. MedRxiv, 2020.04.18.20071134. https://doi.org/10.1101/2020.04.18.20071134

Edridge, A. W., Kaczorowska, J. M., Hoste, A. C., Bakker, M., Klein, M., Jebbink, M. F., Matser, A., Kinsella, C., Rueda, P., Prins, M., Sastre, P., Deijs, M., & Hoek, L. van der. (2020). Coronavirus protective immunity is short-lasting. MedRxiv, 2020.05.11.20086439. https://doi.org/10.1101/2020.05.11.20086439

Liu, T., Wu, S., Tao, H., Zeng, G., Zhou, F., Guo, F., & Wang, X. (2020). Prevalence of IgG antibodies to SARS-CoV-2 in Wuhan—Implications for the ability to produce long-lasting protective antibodies against SARS-CoV-2. MedRxiv, 2020.06.13.20130252. https://doi.org/10.1101/2020.06.13.20130252

Long, Q.-X., Tang, X.-J., Shi, Q.-L., Li, Q., Deng, H.-J., Yuan, J., Hu, J.-L., Xu, W., Zhang, Y., Lv, F.-J., Su, K., Zhang, F., Gong, J., Wu, B., Liu, X.-M., Li, J.-J., Qiu, J.-F., Chen, J., & Huang, A.-L. (2020). Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections. Nature Medicine, 1–5. https://doi.org/10.1038/s41591-020-0965-6

Rosenberg, E. S., Tesoriero, J. M., Rosenthal, E. M., Chung, R., Barranco, M. A., Styer, L. M., Parker, M. M., John Leung, S.-Y., Morne, J. E., Greene, D., Holtgrave, D. R., Hoefer, D., Kumar, J., Udo, T., Hutton, B., & Zucker, H. A. (2020). Cumulative incidence and diagnosis of SARS-CoV-2 infection in New York. Annals of Epidemiology. https://doi.org/10.1016/j.annepidem.2020.06.004

CDC says COVID-19 cases in U.S. may be 10 times higher than reported. (n.d.). NBC News. Retrieved June 26, 2020, from https://www.nbcnews.com/health/health-news/cdc-says-covid-19-cases-u-s-may-be-10-n1232134

Interactive Heat Map - SARS-CoV-2 - Bloom Lab

Starr, T. N., Greaney, A. J., Hilton, S. K., Crawford, K. H., Navarro, M. J., Bowen, J. E., Tortorici, M. A., Walls, A. C., Veesler, D., & Bloom, J. D. (2020). Deep mutational scanning of SARS-CoV-2 receptor binding domain reveals constraints on folding and ACE2 binding [Preprint]. Microbiology. https://doi.org/10.1101/2020.06.17.157982

Bloom Lab. (2020, June 18). "We've experimentally measured how all amino-acid mutations to the #SARSCoV2 spike RBD affect ACE2 binding and expression of folded protein in a deep mutational scanning study led by @tylernstarr & Allie Greaney:https://biorxiv.org/content/10.1101/2020.06.17.157982v1 Why is this important? (1/n)" Twitter. https://twitter.com/jbloom_lab/status/1273468539484213248

Primer Weekly Briefing 01/05/20

Chen, C. (2020, April 28). What Antibody Studies Can Tell You—And More Importantly, What They Can’t. ProPublica. https://www.propublica.org/article/what-antibody-studies-can-tell-you-and-more-importantly-what-they-cant

Lee, S. M. (2020, April 22) Two Antibody Studies Say Coronavirus Infections Are More Common Than We Think. Scientists Are Mad. https://www.buzzfeednews.com/article/stephaniemlee/coronavirus-antibody-test-santa-clara-los-angeles-stanford

Gutman, R. (2020, May 8). You’ll Probably Never Know If You Had the Coronavirus in January. The Atlantic. https://www.theatlantic.com/health/archive/2020/05/us-coronavirus-cases-january/611305/

Robbiani, D. F., Gaebler, C., Muecksch, F., Lorenzi, J. C. C., Wang, Z., Cho, A., Agudelo, M., Barnes, C. O., Gazumyan, A., Finkin, S., Hagglof, T., Oliveira, T. Y., Viant, C., Hurley, A., Hoffmann, H.-H., Millard, K. G., Kost, R. G., Cipolla, M., Gordon, K., … Nussenzweig, M. C. (2020). Convergent Antibody Responses to SARS-CoV-2 Infection in Convalescent Individuals [Preprint]. Immunology. https://doi.org/10.1101/2020.05.13.092619

Crotty, S. (2020, May 14). "Our new paper rapidly studied T cell + antibody immune responses in average COVID-19 cases. This is good news in multiple ways, including coronavirus vaccines. @ljiresearch cell.com/cell/fulltext/..." Twitter. https://twitter.com/profshanecrotty/status/1261052353773363200

WHO “Immunity passports” in the context of COVID-19. (2020 April 27). https://www.who.int/news-room/commentaries/detail/immunity-passports-in-the-context-of-covid-19

Results released for antibody and COVID-19 testing of Boston residents. (2020, May 15). Boston.Gov. https://www.boston.gov/news/results-released-antibody-and-covid-19-testing-boston-residents

Meyer, A. C. M., Robinson. (2020, May 21). ‘How Could the CDC Make That Mistake?’ The Atlantic. https://www.theatlantic.com/health/archive/2020/05/cdc-and-states-are-misreporting-covid-19-test-data-pennsylvania-georgia-texas/611935/

Ahlander, J. & Pollard, N. (2020, May 20). Swedish antibody study shows long road to immunity as COVID-19 toll mounts. Reuters. https://www.reuters.com/article/us-health-coronavirus-sweden-strategy-idUSKBN22W2YC

Devi Sridhar on Twitter: “Early serology results based on antibody testing: 5% for UK, 17% for London. From Matt Hancock, Health Secretary in today’s briefing. In line with what other countries have reported on their seroprevalence.” / Twitter. (n.d.). Twitter. Retrieved May 31, 2020, from https://twitter.com/devisridhar/status/1263507332224475136

Goodman, J. D., & Rothfeld, M. (2020, April 23). 1 in 5 New Yorkers May Have Had Covid-19, Antibody Tests Suggest. The New York Times. https://www.nytimes.com/2020/04/23/nyregion/coronavirus-antibodies-test-ny.html

Vespignani, A., Tian, H., Dye, C. et al. Modelling COVID-19. Nat Rev Phys (2020). https://doi.org/10.1038/s42254-020-0178-4

Larremore, Daniel B., Kate M. Bubar, and Yonatan H. Grad. Implications of test characteristics and population seroprevalence on ‘immune passport’ strategies (May 2020).https://dash.harvard.edu/handle/1/42664007

Wang, C., Li, W., Drabek, D. et al. A human monoclonal antibody blocking SARS-CoV-2 infection. Nat Commun 11, 2251 (2020). https://doi.org/10.1038/s41467-020-16256-y

Kaplan, E. H., & Forman, H. P. (2020). Logistics of Aggressive Community Screening for Coronavirus 2019. JAMA Health Forum, 1(5), e200565–e200565. https://doi.org/10.1001/jamahealthforum.2020.0565

Gray, N., Calleja, D., Wimbush, A., Miralles-Dolz, E., Gray, A., De-Angelis, M., Derrer-Merk, E., Oparaji, B. U., Stepanov, V., Clearkin, L., & Ferson, S. (2020). “No test is better than a bad test”: Impact of diagnostic uncertainty in mass testing on the spread of Covid-19 [Preprint]. Epidemiology. https://doi.org/10.1101/2020.04.16.20067884

Mullard, A. (2020). Flooded by the torrent: The COVID-19 drug pipeline. The Lancet, 395(10232), 1245–1246. https://doi.org/10.1016/S0140-6736(20)30894-1

antibody modeling